Drug Shortage Report for TEVA-FINGOLIMOD
Report ID | 146128 |
Drug Identification Number | 02469561 |
Brand name | TEVA-FINGOLIMOD |
Common or Proper name | FINGOLIMOD 0.5MG CAPS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | FINGOLIMOD |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 30UD |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-09-22 |
Estimated end date | 2022-01-31 |
Actual end date | 2021-11-24 |
Shortage status | Resolved |
Updated date | 2021-11-25 |
Company comments | Item is short-dated/expiring |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-11-25 | French | Compare |
v7 | 2021-11-25 | English | Compare |
v6 | 2021-10-07 | French | Compare |
v5 | 2021-10-07 | English | Compare |
v4 | 2021-09-30 | French | Compare |
v3 | 2021-09-30 | English | Compare |
v2 | 2021-09-23 | French | Compare |
v1 | 2021-09-23 | English | Compare |
Showing 1 to 8 of 8